Back to News
Market Impact: 0.55

Saab year-end report 2025: Record order bookings - building for growth

Corporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Company FundamentalsM&A & RestructuringInfrastructure & DefenseBanking & LiquidityTechnology & Innovation
Saab year-end report 2025: Record order bookings - building for growth

Saab delivered a strong 2025 year-end report with record Q4 order bookings of SEK 100,111m (vs. 17,556) and sales of SEK 27,697m, representing organic sales growth of 34.5%. EBITDA rose to SEK 4,203m (15.2% margin) and EBIT to SEK 3,261m (11.8%), with adjusted EBIT of SEK 2,925m excluding a SEK 336m capital gain from the divestment of Saab TransponderTech AB; net income was SEK 2,568m (EPS SEK 4.73). Operational cash flow improved to SEK 6,281m, net liquidity to SEK 3,989m, and the Board proposes a SEK 2.40 dividend; management upgraded the 2023–2027 medium-term organic sales CAGR target to ~22% (from 18%), citing strong order backlog and continued investment in capacity and capabilities.

Analysis

Market structure: Saab (STO:SAAB B) is a clear near-term winner — SEK 100.1bn Q4 order bookings (vs SEK 17.6bn yr-ago) and an upgraded ~22% organic CAGR through 2027 materially improves revenue visibility and pricing power for Saab and its Swedish supply chain (systems, sensors, naval suppliers). Competitors (BAE.L, LDO.MI, RHM.DE) face asymmetric pressure: prime contracting incumbents lose near-term share in segments where Saab won large awards; credit spreads on Saab should compress ~20–50bp while implied vol may decline as headline risk falls. FX: sustained large foreign orders raise USD/EUR exposure — strengthening SEK would create modest translation headwinds for reported SEK sales. Risk assessment: Tail risks include sudden export-control restrictions (EU/US/SWE) or a single large-order cancellation causing >10–20% revenue swing in a fiscal year, cost overruns from capacity expansion reducing adjusted EBIT margin toward prior ~9–10% levels, and supplier bottlenecks leading to penalty accruals. Immediate (days) risk: post-release reversion if order detail disappoints; short-term (3–6 months): backlog conversion and cash conversion volatility; long-term (2–4 years): capex-driven margin dilution if scale-up mis-executes. Key hidden dependency: concentration — one or two large orders may represent >40–60% of new bookings. Trade implications: Tactical trade — establish a 2–3% long equity position in SAAB B within 2 weeks (target +30% in 12 months, stop-loss -15%) and hedge with a 12-month call spread (buy 20% OTM, sell 40% OTM) sized to cap premium risk. Relative-value: pair long SAAB B vs short BAE Systems (LSE:BA.L) ~1.2:1 to neutralize defence-cyclical beta while capturing Saab-specific backlog re-rate; re-balance on a 10% relative move. Rotate 1–3% of portfolio from cyclical industrials into defense primes and selective supplier credits where spreads widen >40bp. Contrarian angles: Consensus may underweight execution risk and overvalue backlog liquidity — the SEK336m one-off TransponderTech gain and divestment-adjusted EBIT mask sustainable margin drivers; watch for rising working capital as backlog converts. Historical parallels: past large-order spikes at defence peers (e.g., Rheinmetall post-2014) showed sequential margin compression during scale-up. If Q1 order-book granularity reveals >50% concentration in two programs, the market may reprice down 15–25% before reassessing execution, creating a staging point for re-entry.